Antibiotic Resistance Remains High, Says EU Report

EU - Bacteria found in humans, animals and food continue to show resistance to widely used antimicrobials, says the latest report on antimicrobial resistance (AMR) in bacteria by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC).
calendar icon 23 February 2017
clock icon 3 minute read

The findings underline that AMR poses a serious threat to public and animal health. Infections caused by bacteria that are resistant to antimicrobials lead to about 25,000 deaths in the EU every year.

Vytenis Andriukaitis, EU Commissioner for Health and Food Safety, said: “Antimicrobial resistance is an alarming threat putting human and animal health in danger. We have put substantial efforts to stop its rise, but this is not enough. We must be quicker, stronger and act on several fronts. This is why the Commission will launch a new Action Plan this summer that will give a new framework for future coordinated actions to reduce the spread of antimicrobial resistance.”

The report shows that in general multi-drug resistance in Salmonella bacteria is high across the EU. However, experts note that resistance to critically important antimicrobials used to treat severe human cases of Salmonella infection remains low. Salmonellosis, the disease caused by these bacteria, is the second most commonly reported foodborne disease in the EU.

The report also highlights that antimicrobial resistance levels in Europe continue to vary by geographical region, with countries in Northern and Western Europe generally having lower resistance levels than those in Southern and Eastern Europe.

Marta Hugas, Head of EFSA’s Biological Hazards and Contaminants unit, said: “These geographic variations are most likely related to differences in antimicrobial use across the EU. For example, countries where actions have been taken to reduce, replace and re-think the use of antimicrobials in animals show lower levels of antimicrobial resistance and decreasing trends.”

Among the other findings, more than 10 per cent of the tested Campylobacter coli bacteria in humans showed resistance to two critically important antimicrobials (fluoroquinolones and macrolides), which are used to treat severe cases of Campylobacter infections in humans. Campylobacteriosis is the most commonly reported foodborne disease in the EU.

© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.